東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/08/08 | 2,630 | 2,643 | 2,594 | 2,633 | -10 | -0.4% | 131,300 |
2019/08/07 | 2,639 | 2,658 | 2,610 | 2,643 | +4 | +0.2% | 179,600 |
2019/08/06 | 2,600 | 2,639 | 2,551 | 2,639 | -21 | -0.8% | 141,900 |
2019/08/05 | 2,686 | 2,699 | 2,625 | 2,660 | -50 | -1.8% | 127,200 |
2019/08/02 | 2,728 | 2,775 | 2,685 | 2,710 | -58 | -2.1% | 139,800 |
2019/08/01 | 2,753 | 2,787 | 2,739 | 2,768 | +24 | +0.9% | 127,100 |
2019/07/31 | 2,755 | 2,786 | 2,736 | 2,744 | -56 | -2% | 176,500 |
2019/07/30 | 2,774 | 2,800 | 2,769 | 2,800 | +27 | +1% | 80,700 |
2019/07/29 | 2,770 | 2,791 | 2,764 | 2,773 | -6 | -0.2% | 65,800 |
2019/07/26 | 2,769 | 2,785 | 2,757 | 2,779 | -11 | -0.4% | 79,300 |
2019/07/25 | 2,835 | 2,835 | 2,790 | 2,790 | -14 | -0.5% | 93,900 |
2019/07/24 | 2,836 | 2,840 | 2,790 | 2,804 | -32 | -1.1% | 107,200 |
2019/07/23 | 2,803 | 2,841 | 2,798 | 2,836 | +33 | +1.2% | 84,900 |
2019/07/22 | 2,858 | 2,861 | 2,801 | 2,803 | -70 | -2.4% | 124,700 |
2019/07/19 | 2,848 | 2,898 | 2,834 | 2,873 | +25 | +0.9% | 123,000 |
2019/07/18 | 2,891 | 2,908 | 2,843 | 2,848 | -52 | -1.8% | 224,900 |
2019/07/17 | 2,878 | 2,908 | 2,850 | 2,900 | +8 | +0.3% | 125,900 |
2019/07/16 | 2,850 | 2,907 | 2,837 | 2,892 | +50 | +1.8% | 160,700 |
2019/07/12 | 2,891 | 2,905 | 2,837 | 2,842 | -49 | -1.7% | 96,300 |
2019/07/11 | 2,895 | 2,910 | 2,877 | 2,891 | +4 | +0.1% | 90,900 |
2019/07/10 | 2,834 | 2,892 | 2,834 | 2,887 | +20 | +0.7% | 105,000 |
2019/07/09 | 2,870 | 2,889 | 2,860 | 2,867 | -1 | ±0% | 56,600 |
2019/07/08 | 2,872 | 2,884 | 2,837 | 2,868 | -22 | -0.8% | 153,800 |
2019/07/05 | 2,881 | 2,890 | 2,854 | 2,890 | +10 | +0.3% | 67,200 |
2019/07/04 | 2,890 | 2,905 | 2,863 | 2,880 | -9 | -0.3% | 63,000 |
2019/07/03 | 2,870 | 2,889 | 2,859 | 2,889 | +19 | +0.7% | 99,600 |
2019/07/02 | 2,815 | 2,870 | 2,800 | 2,870 | +53 | +1.9% | 115,200 |
2019/07/01 | 2,776 | 2,818 | 2,776 | 2,817 | +81 | +3% | 152,600 |
2019/06/28 | 2,724 | 2,781 | 2,724 | 2,736 | -21 | -0.8% | 134,400 |
2019/06/27 | 2,773 | 2,777 | 2,754 | 2,757 | -29 | -1% | 86,100 |
2019/06/26 | 2,788 | 2,809 | 2,775 | 2,786 | +1 | ±0% | 99,300 |
2019/06/25 | 2,801 | 2,819 | 2,783 | 2,785 | -3 | -0.1% | 87,400 |
2019/06/24 | 2,827 | 2,827 | 2,776 | 2,788 | -39 | -1.4% | 72,400 |
2019/06/21 | 2,851 | 2,853 | 2,802 | 2,827 | -5 | -0.2% | 139,700 |
2019/06/20 | 2,833 | 2,853 | 2,814 | 2,832 | +11 | +0.4% | 81,800 |
2019/06/19 | 2,840 | 2,855 | 2,817 | 2,821 | +27 | +1% | 151,900 |
2019/06/18 | 2,808 | 2,842 | 2,792 | 2,794 | +10 | +0.4% | 90,800 |
2019/06/17 | 2,813 | 2,815 | 2,774 | 2,784 | -43 | -1.5% | 66,200 |
2019/06/14 | 2,818 | 2,838 | 2,798 | 2,827 | +25 | +0.9% | 169,000 |
2019/06/13 | 2,783 | 2,835 | 2,783 | 2,802 | +7 | +0.3% | 209,700 |
2019/06/12 | 2,750 | 2,806 | 2,747 | 2,795 | +37 | +1.3% | 117,000 |
2019/06/11 | 2,753 | 2,776 | 2,736 | 2,758 | -8 | -0.3% | 115,300 |
2019/06/10 | 2,740 | 2,771 | 2,729 | 2,766 | +46 | +1.7% | 145,900 |
2019/06/07 | 2,694 | 2,720 | 2,668 | 2,720 | +53 | +2% | 117,500 |
2019/06/06 | 2,633 | 2,690 | 2,633 | 2,667 | -16 | -0.6% | 90,300 |
2019/06/05 | 2,676 | 2,684 | 2,644 | 2,683 | +86 | +3.3% | 139,100 |
2019/06/04 | 2,607 | 2,611 | 2,573 | 2,597 | +2 | +0.1% | 98,700 |
2019/06/03 | 2,598 | 2,611 | 2,568 | 2,595 | -7 | -0.3% | 103,800 |
2019/05/31 | 2,670 | 2,680 | 2,602 | 2,602 | -81 | -3% | 113,400 |
2019/05/30 | 2,726 | 2,737 | 2,666 | 2,683 | -65 | -2.4% | 125,300 |
1401~
1450
件表示中 / 6946件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 262,500円 | +15.0% | -7.3% | 2.67% | 8.61倍 | 0.81倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
サンバイオ | 231,700円 | - | - | 0.00% | - | 107.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 558,000円 | +7.1% | -35.0% | 2.15% | 46.14倍 | 1.29倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 233,800円 | +14.2% | +41.0% | 1.97% | 11.45倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 231,800円 | +21.7% | +999.9% | 0.00% | 9.65倍 | 3.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム